Cytosorbents Corp
CTSO
85 hedge funds and large institutions have $69.9M invested in Cytosorbents Corp in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 11 closing their positions.
162% more call options, than puts
Call options by funds: $450K | Put options by funds: $172K
64% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 11
8% more funds holding
Funds holding: 79 → 85 (+6)
1.3% more ownership
Funds ownership: 26.06% → 27.35% (+1.3%)
9% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 22
34% less capital invested
Capital invested by funds: $106M → $69.9M (-$35.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.21M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$922K |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$902K |
| 4 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
+$897K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$741K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$1.88M |
| 2 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$1.08M |
| 3 |
JP Morgan Chase
New York
|
-$875K |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$394K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$393K |
CTSO Hedge Fund Activity: Q4 2018 in Review
85 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q4 2018, worth a combined $69.9M — down 34% from $106M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new CTSO positions and 11 closed out — a net gain of 7 holders — while 24 added to existing stakes and 22 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $1.21M. The largest seller was Invesco, cutting an estimated $1.88M.
- 85 institutional investors held Cytosorbents Corp (CTSO) as of Q4 2018, up from 79 in Q3 2018.
- Funds reported $69.9M of Cytosorbents Corp stock for Q4 2018, down 34% quarter-over-quarter.
- 18 funds opened new Cytosorbents Corp positions in Q4 2018 and 11 closed out, a net change of +7 holders.
- The largest Cytosorbents Corp buyer in Q4 2018 was Renaissance Technologies, an estimated $1.21M added.
- The largest Cytosorbents Corp seller in Q4 2018 was Invesco, an estimated $1.88M sold.
Based on aggregated 13F filings for Q4 2018.